Blood Product Transfusion for All ConditionsPopReceveurNCT03313583
French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients
An observational study of Blood Product Transfusion for All Conditions and Trauma, run by Etablissement Français du Sang.
Trial summary
Describe the epidemiologic profile and clinical context of transfusion recipients in France. Describe the clinical context of transfusion. Describe the characteristics of the transfusion prescriptions, the use of blood products and the main indications for transfusion. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Blood Product Transfusion for All Conditions, Trauma, Surgical Blood Loss
- What is being tested?
- Transfusion of blood products
- Type of treatment
- Surgery or procedure
- How many people
- 4,720 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2011to 1 Dec 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: french population of recipients
Who may be able to join
- Transfusion with at least one blood product on the day of the study.
Who cannot join
- None
About this study
Official title: French Transfusion Recipients Cross Sectional Study : Get to Know the Transfusion Recipients Population
Describe the epidemiologic profile and clinical context of transfusion recipients in France. Describe the clinical context of transfusion.
Describe the characteristics of the transfusion prescriptions, the use of blood products and the main indications for transfusion.
Describe transfusion practice according the type of hospital stay.
- Conditions
- Blood Product Transfusion for All Conditions, Trauma, Surgical Blood Loss, Hematologic Diseases
- Being tested
- Transfusion of blood products
- Medical subject headings
- Wounds and Injuries, Blood Loss, Surgical, Hematologic Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transfusion of blood productsProcedure or surgery
| Study group | Role | What they receive |
|---|---|---|
| Blood product recipients | All patients who received at least one blood product on the day of the study Receives: Procedure: Transfusion of blood products |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of red blood cell concentrates received
transversal study
Measured: 1 day (cross sectional)
Number of platelet concentrates recevied
transversal study
Measured: 1 day (cross sectional)
Number of plasma units received
transversal study
Measured: 1 day (cross sectional)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Oct 2017
- Study start1 Nov 2011
- Primary completion1 Nov 2011
- Study completion1 Dec 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Blood Product Transfusion for All ConditionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 4,720 participants (actual)
Sponsor and investigators
- Lead sponsor
- Etablissement Français du Sang
- Sponsor type
- University, hospital or other
- Collaborators
- Centre Hospitalier Universitaire de Besancon, Centre Hospitalier Universitaire de Nice, Assistance Publique Hopitaux De Marseille, Région Nord-Pas de Calais, France
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03313583
- Sponsor's protocol ID
- EFS/2011/PopReceveur
- Acronym
- PopReceveur
- Status last verified
- Oct 2017
- First submitted
- 29 Sep 2017
- Last updated
- 18 Oct 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Fillet AM, Desmarets M, Assari S, Quaranta JF, Francois A, Pugin A, Schuhmacher A, Lassale B, Monnet E, Cabre P, Legrand D, Binda D, Djoudi R. Blood products use in France: a nationwide cross-sectional survey. Transfusion. 2016 Dec;56(12):3033-3041. doi: 10.1111/trf.13887. Epub 2016 Nov 2.
PubMed 27807857
Study at a glance
From the registry record, last updated by the sponsor on 18 Oct 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- French Transfusion Recipients Cross Sectional Study : Get to Know the Transfusion Recipients Population
- ClinicalTrials.gov ID
- NCT03313583
- Acronym / sponsor ID
- PopReceveur / EFS/2011/PopReceveur
- Conditions
- Blood Product Transfusion for All Conditions, Trauma, Surgical Blood Loss, Hematologic Diseases
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,720 participants (actual)
- Lead sponsor
- Etablissement Français du SangUniversity, hospital or other
- Collaborators
- Centre Hospitalier Universitaire de Besancon, Centre Hospitalier Universitaire de Nice, Assistance Publique Hopitaux De Marseille, Région Nord-Pas de Calais, France
- Study start
- 1 Nov 2011 (actual)
- Primary completion
- 1 Nov 2011 (actual)
- Study completion
- 1 Dec 2011 (actual)
- First posted
- 18 Oct 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Describe the epidemiologic profile and clinical context of transfusion recipients in France. Describe the clinical context of transfusion.
Describe the characteristics of the transfusion prescriptions, the use of blood products and the main indications for transfusion.
Describe transfusion practice according the type of hospital stay.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Blood product recipients | – | Procedure: Transfusion of blood productsAll patients who received at least one blood product on the day of the study |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- french population of recipients
Key inclusion criteria (1 listed)
- Transfusion with at least one blood product on the day of the study.
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transfusion of blood products | Procedure or surgery | Blood product recipients |
Primary outcome
Number of red blood cell concentrates received
Time frame: 1 day (cross sectional)
transversal study
Number of platelet concentrates recevied
Time frame: 1 day (cross sectional)
transversal study
Number of plasma units received
Time frame: 1 day (cross sectional)
transversal study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Oct 2017.
- Results publication: PubMed 27807857Fillet AM, Desmarets M, Assari S, Quaranta JF, Francois A, Pugin A, Schuhmacher A, Lassale B, Monnet E, Cabre P, Legrand D, Binda D, Djoudi R. Blood products use in France: a nationwide cross-sectional survey. Transfusion. 2016 Dec;56(12):3033-3041. doi: 10.1111/trf.13887. Epub 2016 Nov 2.
- Individual participant dataSharing planned: Undecided
Related trials for Blood Product Transfusion for All Conditions
Not yet recruitingObservational study
Patient Blood Management in Obstetrics
Patient Blood Management, Blood Product Transfusion for All Conditions
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Blood Product Transfusion for All Conditions and Trauma, run by Etablissement Français du Sang.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of red blood cell concentrates received (time frame: 1 day (cross sectional)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03313583, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Oct 2017.